life science conferences

World Generic Medicines Congress Europe 2010 addresses the health economics, pricing and competition pressures facing the generics sector in Europe and building scale and value through globalisation.

Drug Discovery Technology World Asia will bring together scientists and discovery technology providers from Asia and globally to discuss and share new tools, innovative methodologies and novel cutting-edge technologies that can be utilized to fast track biomarker research and drug discovery.

This event will bring together biopharmaceutical manufacturers, biotechs, research and academic institutions and contract manufacturing providers to discuss manufacturing opportunities in Asia, as well as methodologies and technologies to improve productivity, efficiency and profitability.

An event bringing together pharmas, biotechs, and CROs to explore offshoring & outsourcing opportunities in Asia for cost effective preclinical and clinical drug development.

This event brings together pharmas, biotechs, research and academic institutions to evaluate partnering opportunities. It’s a platform for showcasing discovery and innovation for out-licensing and capital raising.

BioPharma Asia Convention 2010 is uniquely positioned as Asia's only exhibition that showcases leading technocrats, solution and service suppliers across the entire value chain of the biopharma indstury in Asia!

The 4th annual Pharma Pricing & Market Access Outlook is the World’s largest pricing, reimbursement and market access event for the pharmaceutical and biotech community.

Late Phase Drug Development World Americas 2010 is the first ever strategic forum addressing the major challenges in conducting strategic and compliant late stage studies for pharmaceutical and biotech companies.

Now in its 10th year, World Vaccine Congress 2009 remains the industry’s definitive vaccine industry event for major vaccine players and their respective senior level representatives

Healthcare World Australia 2010 features a mix of leaders from Government, healthcare providers, technology enablers, CDM program managers and independent experts, this three day conference will focus on the issues that matter.

The 2nd annual World Drug Safety Congress Americas addresses the key challenges for drug safety & pharmacovigilance professionals Worldwide. The World Drug Safety Congress addresses the crucial issues in the development and execution of drug safety programmes.

The Vaccine Industry Excellence Awards have been created to honor and generate recognition of the efforts, accomplishments, and positive contributions of companies and individuals in the vaccine industry.

Now in its 5th year, the annual World Stem Cells & Regenerative Medicine Congress is the world's largest and most influential event to address the commercialisation of stem cells and regenerative medicines.

Europe’s largest and most influential early development / phase I congress will address the critical issues in achieving seamless first in man studies and will provide advice on conducting effective studies that allow you to make the right decision early on in clinical development

World Vaccine Congress Asia 2010 is the annual meeting of vaccine buyers and sellers, NGOs, health authorities, regulators, vaccine producers and manufacturers, and other stakeholders come together to discuss industry trends, opportunities, new vaccines and new technology innovations across Asia!

Asia Infectious Disease Forum is the ONLY event in Asia bringing together CDCs, NGOs, public and private research institutes, pharma and biotech companies from Asia and globally in one platform to address challenges facing the infectious disease prevention today.

Vaccine Industry Excellence (ViE) Asia Awards will be an integral part of the annual World Vaccine Congress Asia. Taking place on the evening of the 9th of June 2010, ViE Asia Awards will be recognizing the outstanding achievements of vaccine practitioners and stakeholders operating in Asia.

Pharma Trials Asia 2010 is where the world’s top pharmas, biotechs, CROs, lawyers, and regulators convene to provide the most comprehensive knowledge into the best operational strategies and practices in fast-tracking pre-clinical and clinical drug development in Asia.

Stem Cells USA & Regenerative Medicine Congress 2010 is where global pharmaceutical companies, biotechs, academics and investors gather to discuss innovation, market opportunities and partnership models.

The 4th annual World Drug Safety Congress in Europe addresses the key challenges for drug safety professionals Worldwide. The World Drug Safety Congress addresses the crucial issues in the development and execution of drug safety programmes.

The 2010 Targeted Cancer Therapy World Congress is an executive-level, interactive conference experience tackling the biggest issues facing the oncology industry today.

DigiPharm Europe 2010 is one of the largest gatherings of pharmaceutical marketing and communications professionals in Europe. Benchmark strategies to enhance online communication, customer relations, brand awareness and profitability in digital marketing.

World Vaccine Congress Lyon 2009 is Europe's largest and most influential vaccine event. World Vaccine Congress Lyon features an in-depth agenda, an elite speaker panel, and a focus on business strategy.

Market Access World USA will attract a record number of pharma market access thought leaders. This event will provide delegates with the most comprehensive review of US health reform.

The 3rd annual Exploratory Clinical Development World Americas follows the huge success of the inaugural conference in September 2008, to which Health Network attracted a record number of early development scientists and decision makers to explore the challenges of Phase I trials.

Influenza Congress USA is THE annual influenza conference in North America addressing every aspect of influenza policy and planning, influenza research & development and stakeholder partnerships.

World Generic Medicines Congress Americas 2010 addresses the health economics, pricing and competition pressures facing the generics sector in Europe and building scale and value through globalisation.

The European Antibody Congress is Europe’s definitive antibody event, bringing together thought leaders from across the industry. This lively and energetic meeting combines expert speakers, cutting-edge case studies, dedicated networking in an environment where discussion and debate thrives.

The 2nd annual Late Phase Drug Development World 2010 is the first ever strategic forum addressing the major challenges in conducting strategic and compliant late stage studies for pharmaceutical and biotech companies.

World Influenza Congress Europe is the annual influenza conference addressing every aspect of influenza policy and planning, influenza research & development, and stakeholder partnerships.

Health Technology Assessment World Europe 2010 is the 3rd annual policy forum for the industry where all the major HTA agencies across the world and leading pharmaceutical companies discuss the challenges in obtaining market access.